Skip to main content
$24.39 -$0.16 (-0.7%)

04:00 PM EDT on 10/15/21

Pacific Biosciences of California, Inc. (NASDAQ:PACB)

CAPS Rating: 3 out of 5

Current Price $24.39 Mkt Cap $5.3B
Open $25.10 P/E Ratio 0.00
Prev. Close $24.39 Div. (Yield) $0.00 (0.0%)
Daily Range $24.12 - $25.10 Volume 1,463,864
52-Wk Range $11.22 - $53.69 Avg. Daily Vol. 1,728,537

Caps

How do you think NASDAQ:PACB will perform against the market?

Add Stock to CAPS Watchlist

All Players

249 Outperform
23 Underperform
 

All-Star Players

56 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:PACB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Breq (76.71)
Submitted July 19, 2016

The rational is the same as for Illumina. Genome sequencing will take on greater and greater importance in the future.

TSIF (99.99)
Submitted October 05, 2015

Releasing a lower cost option should ultimately be good for the bottom line...at least in this case.Sometimes too many models confuses customers and erodes the higher margin upper end of the offering, but in this case, the high end was so high,… More

NASDAQ:PACB VS S&P 500 (SPY)

Fools bullish on NASDAQ:PACB are also bullish on:

Fools bearish on NASDAQ:PACB are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PACB.

Recs

0
Member Avatar TMFRyanTotz (< 20) Submitted: 8/8/2021 6:07:26 PM : Outperform Start Price: $32.11 NASDAQ:PACB Score: -25.57

One of the major players in both DNA and Epigenetic sequencing technology. If genomic testing becomes common place (like blood tests) in medicine, PACB could have lasting positive impact for science, medicine and society. Could likely 10X over the next 8-10 years.

Recs

0
Member Avatar TMFRetireFoolish (< 20) Submitted: 7/8/2021 1:22:52 AM : Outperform Start Price: $33.21 NASDAQ:PACB Score: -31.28

Potential to take leadership role with long read sequencing

Recs

0
Member Avatar 1russianguy (94.93) Submitted: 2/23/2021 1:01:53 PM : Outperform Start Price: $39.35 NASDAQ:PACB Score: -53.16

Three Stocks With 1,000% ROI Potential, as of Feb. 21'. https://www.youtube.com/watch?v=URCkYR_0Ws8

Leaderboard

Find the members with the highest scoring picks in PACB.

Score Leader

IdahoAve

IdahoAve (83.85) Score: +1,179.88

The Score Leader is the player with the highest score across all their picks in PACB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
IdahoAve 83.85 11/28/2012 Outperform 5Y $1.61 +1,398.76% +218.87% +1,179.88 0 Comment
codyjr002 77.42 8/22/2012 Outperform 5Y $1.81 +1,233.15% +215.67% +1,017.48 0 Comment
AFMS 45.25 8/31/2012 Outperform 5Y $1.92 +1,158.08% +215.00% +943.08 0 Comment
snscblue1 75.49 9/13/2012 Outperform 5Y $2.00 +1,106.50% +203.87% +902.63 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. franniemarie 73.22 7/25/2012 6/19/2018 Outperform 5Y $1.98 +1,118.69% +233.18% +885.51 0 Comment
mattyabe < 20 6/25/2012 Outperform 5Y $2.00 +1,106.50% +237.49% +869.01 1 Comment
fiveforthemoney 97.18 7/25/2012 Outperform NS $2.03 +1,088.67% +231.82% +856.85 0 Comment
TexasChris 63.83 3/18/2013 Outperform 5Y $2.22 +986.94% +188.75% +798.19 0 Comment
vivsiv < 20 4/15/2013 Outperform 3Y $2.34 +931.20% +182.06% +749.13 0 Comment
AndreyGR < 20 5/22/2012 Outperform 5Y $2.24 +977.23% +235.76% +741.47 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PACB.